Blockade of Tumor TAK1 Induces DNA Damage and Immunogenic cGAS-STING Pathway Activation in Pancreatic Cancer
Listen to this summary
The authors investigate the role of TGF-β-activated kinase 1 (TAK1) in pancreatic ductal adenocarcinoma (PDAC) and its impact on T cell dysfunction within the tumor microenvironment. They demonstrate that inhibiting TAK1 enhances T cell infiltration and activates the cGAS-STING pathway, leading to DNA damage and inflammatory responses that could sensitize PDAC to immune checkpoint blockade therapy. This study identifies TAK1 as a potential therapeutic target for reversing the immunologically "cold" nature of PDAC.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Gastroenterology
View all →May 9, 2026 · Gastroenterology
Randomized Sham Controlled Trial of Translumbosacral Neuromodulation Therapy for Fecal Incontinence
May 8, 2026 · Gastroenterology
Neutrophil-Driven Trogocytosis in PDAC Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic Progression
May 1, 2026 · Gastroenterology
Recommendations for the Evaluation and Management of Inflammatory Bowel Disease with Irritable Bowel Syndrome-Like Symptoms: A Joint Rome Foundation and International Organization for the Study of IBD (IOIBD) Consensus
May 1, 2026 · Gastroenterology
Bioengineering a probiotic to bloom during colonic inflammation promotes reliable efficacy in translational models of colitis
Apr 29, 2026 · Gastroenterology
Chronic Pancreatitis: Mechanisms of Inflammation, Pathways of Progression and Emerging Therapeutic Strategies
Apr 24, 2026 · Gastroenterology
Design of Treatment Trials for Disorders of Gut-Brain Interaction
More in Internal Medicine
View all →May 10, 2026 · JAMA
Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis
May 10, 2026 · European heart journal
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 10, 2026 · JAMA
Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial
May 10, 2026 · European heart journal
Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
